<DOC>
	<DOCNO>NCT01638468</DOCNO>
	<brief_summary>The purpose European Post Market Follow-up Plan design evaluate safety , efficacy , adverse event new information may surface regard use AngioJet Ultra PE Thrombectomy Catheter System patient thrombus main pulmonary lobar artery ≥ 6mm diameter .</brief_summary>
	<brief_title>Multicenter , Nonrandomized , Prospective Study Pulmonary Embolism Removal With AngioJet 6F Ultra System</brief_title>
	<detailed_description>Despite advance prophylaxis , diagnostic modality , therapeutic option , pulmonary embolism remain commonly diagnose lethal entity . In United States approximately 150,000 patient per year diagnose acute pulmonary embolism . Many additional death occur year United States result undiagnosed massive pulmonary embolism . Taking patient account , think 600,000 patient develop pulmonary embolism annually country . In patient acute pulmonary embolism , common cause early death right ventricular failure . In addition anticoagulation therapy , several reperfusion therapy use reverse right ventricular failure : systemic thrombolysis , surgical embolectomy , catheter base therapy . Given drawback systemic thrombolytic therapy surgical embolectomy , percutaneous catheter treatment reasonable alternative patient contraindication systemic thrombolytic therapy surgery . Current international consensus guideline support use catheter intervention select pulmonary embolism patient increase risk adverse clinical outcome . The AngioJet Ultra PE Thrombectomy catheter introduces pressurize high velocity saline stream catheter tip clot within blood vessel trap , break small piece aspirate body .</detailed_description>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>1 . Symptomatic pulmonary embolism patient &gt; 18 year 2 . Availability baseline contrastenhanced chest compute tomogram conventional pulmonary angiogram evidence pulmonary embolus least one main lobar pulmonary artery ≥ 6mm diameter 3 . Availability baseline transthoracic echocardiogram sufficient image quality permit measurement right ventricular ( RV ) leave ventricular ( LV ) dimension apical subcostal fourchamber view 4 . Echocardiographic evidence right ventricular dilatation subannular RV/LV ratio ≥ 0.9 apical subcostal fourchamber view 5 . Appropriate inform consent obtain patient legal representative 1 . Patient underwent Cardiopulmonary Resuscitation ( CPR ) last 48 hour 2 . Patient participate clinical study 3 . Pregnancy , lactation parturition within previous 30 day ( positive pregnancy test , woman childbearing age must test use medically accept method birth control ) 4 . Inability comply study Followup assessment ( e.g . due geographic ) 5 . Previous enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>Acute Pulmonary Embolism</keyword>
	<keyword>Sub-massive Pulmonary Embolism</keyword>
	<keyword>Massive Pulmonary Embolism</keyword>
	<keyword>Pulmonary Thromboembolism</keyword>
</DOC>